Camurus announces FDA acceptance of NDA resubmission for Oclaiz™ for the treatment of acromegaly

Camurus (NASDAQ STO: CAMX) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the company's resubmission of the New Drug Application (NDA) for Oclaiz™ (CAM2029), ...

Camurus AB: Camurus announces FDA acceptance of NDA resubmission for Oclaiz for the treatment of acromegaly

Oclaiz is a subcutaneous long-acting octreotid depot, designed for optimized disease control and convenient self-administration. The product is based on Camurus' FluidCrystal technology and is ...

Cerro de Pasco Resources Provides Operational Review, Project Progress and Corporate Update

Cerro de Pasco Resources Inc. (TSXV CDPR) (OTCQB GPPRF) (FRA N8HP) (the Company or CDPR) is pleased to provide an operational review and corporate update highlighting ...
IMD Business School

In the field with Absa

At a glance Absa addressed its cybersecurity talent challenge by training underprivileged youth, creating both business value and social impact. To overcome its lack of in-house experience in ...
Goldseiten

Vanguard Mining Completes Drill Program With Assays Now Pending at Redonda Copper-Molybdenum Project, British Columbia

Vanguard Mining Corp. is pleased to announce it has completed its Q4 drill program drilling to a total depth of 511 metres at ...